Literature DB >> 6387532

Bone marrow transplant in adrenoleukodystrophy.

H W Moser, P J Tutschka, F R Brown, A E Moser, A M Yeager, I Singh, S A Mark, A A Kumar, J M McDonnell, C L White.   

Abstract

An allogeneic bone marrow transplant (BMT) from a normal HLA identical sibling donor was performed in a 13-year-old boy with rapidly progressive adrenoleukodystrophy (ALD). Engraftment and complete hematologic recovery occurred within 4 weeks, but neurologic deterioration continued. The patient died of an adenovirus infection 141 days after BMT. ALD is characterized by abnormally high plasma levels of very long chain fatty acids (VLCFA) as a result of impaired capacity to degrade them. Ten days after BMT, the white blood cell VLCFA levels and enzyme activity became normal; after 3 months, there was progressive reduction of plasma VLCFA to levels only slightly above normal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387532     DOI: 10.1212/wnl.34.11.1410

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  X-linked adrenoleukodystrophy: first report of the Italian Study Group.

Authors:  A Di Biase; S Salvati; C Avellino; M Cappa; E Bertini; I Moroni; M Rimoldi; G Uziel
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  A family with adrenoleucodystrophy.

Authors:  R P Singh; S Deshpande; R K Marwaha; K Garg
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

4.  Adrenoleucodystrophy.

Authors:  S H Green
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

5.  A novel mutation found in an adrenoleukodystrophy patient who underwent bone marrow transplantation.

Authors:  H Osaka; H Sekiguchi; K Inoue; K Ikuta; Y Sakakihara; A Oka; H Onishi; T Miyakawa; K Suzuki; S Kimura; K Kosaka; S Matsuyama
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

Review 6.  Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.

Authors:  P A Watkins; S Naidu; H W Moser
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

7.  Contribution of MRI to the diagnosis of cerebral lesions of adrenoleukodystrophy.

Authors:  A Pasco; G Kalifa; J L Sarrazin; C Adamsbaum; P Aubourg
Journal:  Pediatr Radiol       Date:  1991

Review 8.  Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Authors:  Sandra Sirrs; Fady Hannah-Shmouni; Stephen Nantel; James Neuberger; Eric M Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-02-01       Impact factor: 4.982

Review 9.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  Familial spinocerebellar degeneration as an expression of adrenoleukodystrophy.

Authors:  T Kobayashi; S Noda; H Umezaki; I Goto; S Suzuki; T Kitaguchi; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.